Meropenem-vaborbactam: Difference between revisions

From IDWiki
Content deleted Content added
Created page with "== Background == === Mechanism of Activity === * Vaborbactam is active against KPC carbapenemases == Safety == === Monitoring === * Seizures, thrombocytopenia, drug inter..."
 
No edit summary
 
(One intermediate revision by the same user not shown)
Line 4: Line 4:


* Vaborbactam is active against KPC carbapenemases
* Vaborbactam is active against KPC carbapenemases

== Dosing ==

* Carbapenem-resistant infection with [[Enterobacterales]]: 4 g IV every 8 hours
* Complicated [[urinary tract infection]]: 4 g IV every 8 hours for 5 to 14 days

=== Renal Dosing ===
{| class="wikitable"
!eGFR
!Dose
|-
|≥50
|4 g IV every 8 hours (normal dose)
|-
|30 to 49
|2 g IV every 8 hours
|-
|15 to 29
|2 g IV every 12 hours
|-
|<15
|1 g IV every 12 hours
|-
|IHD
|1 g IV every 12 hours
|-
|PD
|1 g IV every 12 hours
|-
|CRRT
|2 g IV every 8 hours
|}


== Safety ==
== Safety ==

Latest revision as of 16:09, 27 June 2025

Background

Mechanism of Activity

  • Vaborbactam is active against KPC carbapenemases

Dosing

Renal Dosing

eGFR Dose
≥50 4 g IV every 8 hours (normal dose)
30 to 49 2 g IV every 8 hours
15 to 29 2 g IV every 12 hours
<15 1 g IV every 12 hours
IHD 1 g IV every 12 hours
PD 1 g IV every 12 hours
CRRT 2 g IV every 8 hours

Safety

Monitoring

  • Seizures, thrombocytopenia, drug interaction with valproic acid